Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
暂无分享,去创建一个
[1] D E Low,et al. Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus , 1992, Journal of clinical microbiology.
[2] M. Kelly,et al. Comparison of three automated systems for antimicrobial susceptibility testing of gram-negative bacilli , 1982, Journal of clinical microbiology.
[3] Derek F. J. Brown,et al. Evaluation of the E test, a novel method of quantifying antimicrobial activity. , 1991, The Journal of antimicrobial chemotherapy.
[4] J. Tokars,et al. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci , 1993 .
[5] C Thornsberry,et al. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria , 1991, Journal of clinical microbiology.
[6] R. Sykes,et al. Aztreonam: the first monobactam. , 1985, The American journal of medicine.
[7] C. Stratton,et al. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. , 1992, Diagnostic microbiology and infectious disease.
[8] D. Low,et al. Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1 , 1993, Journal of clinical microbiology.
[9] D E Low,et al. Detection of vancomycin resistance in Enterococcus species , 1992, Journal of clinical microbiology.
[10] L. Gerckens,et al. Antibacterial activity of imipenem: the first thienamycin antibiotic. , 1985, Reviews of infectious diseases.